Modification to Bd Facscanto System with Bd Facscanto Clinical Software
by Becton, Dickinson & CO 510(k)
Active
510(k) K050191
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK050191 | Date22 Feb 2005 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
-
- Terminated Z-2356-2020
The recalling firm confirmed that BD FACS Sample Prep Assistant (SPA) II and III users may encounter probes with unacceptable wear prior to reaching the 2500 piercings guideline indicated in the Instructions for Use (IFU). When the probe is worn, particles from the rubber cap are more likely to clog the probe, resulting in blocked or inadequate sample dispense.
-
- Terminated Z-2357-2020
The recalling firm confirmed that SPA II and III users may encounter probes with unacceptable wear prior to reaching the 2500 piercings guideline indicated in the Instructions for Use (IFU). When the probe is worn, particles from the rubber cap are more likely to clog the probe, resulting in blocked or inadequate sample dispense.
-
- Terminated Z-1940-2010
Samples prepared on the BD SPA II, SN T0076 produced inaccurate sample results due to inaccurate sample dispensed as a result of the cap piercing probe
-
- Terminated Z-0526-2008
Mixing Performance: SPA II devices manufactured with the affected product motor control board may exhibit suboptimal mixing performance.
Specification
- 510(k) Number
- FDA Product Code
- PER
- Device Class
- Class I
- Regulation
- 21 CFR Part 862.2750
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent